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osting by EAbstract Two ﬂavonols identiﬁed as 3,5,7,40-tetrahydroxy-30-methoxyﬂavone (1) and 3,5,7,40-
tetrahydroxy-8-methoxyﬂavone (2) were isolated from the seeds of Calycotome villosa subsp.
intermedia. The structure elucidation of the isolated compounds was performed by the spectro-
scopic methods (UV, IR, 1H NMR, 13C NMR and MS) and also by a single crystal X-ray analysis
in the case of compound (2). Vasodilator activity of compound (2) was demonstrated in isolated rat
aorta contracted with high KCl or with noradrenaline.
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lsevier1. Introduction
Flavonoids constitute one of the largest group of polyphenols
which are widely distributed throughout the plant kingdom
(Bohm, 1998). To date, more than 4000 ﬂavonoids have been
described (Bravo, 1998). Flavonoids exhibit several biological
activities and have free radical scavenging abilities and contrib-
ute to antioxidant capacity in fruits and vegetables (Morel
et al., 1993; Cao et al., 1997). The antioxidant activity of some
subclasses of the ﬂavonoids, such as the ﬂavonols, has been
174 A.E. Antri et al.reported to be greater than that of either vitamin C or E (Rice-
Evans et al., 1995; Bors et al., 1990). Antihypertensive activity
and direct vasodilator effect of ﬂavonoids have been reported
(Duarte et al., 1993; 2001; Ibarra et al., 2003; Perez-Vizcaino
et al., 2002). Recent work demonstrates the importance of
the chemical nature of these compounds to their bioactivity
and bioavailability (Plumb et al., 1997). These ﬁndings suggest
that the degree of hydroxylation is important in determining
the antioxidant activity.
In previous phytochemical studies of Calycotome villosa
(Poiret) Link subsp. intermedia (C.Presl) Quezel and Santa
(Leguminosae), we have reported the isolation and character-
ization of ﬂavone glucosides from the leaves and ﬂowers (El
Antri et al., 2004a) and alkaloids from the seeds (El Antri
et al., 2004b,c). Further chemical investigation of the seeds
of this species revealed the presence of a complex mixture of
ﬂavonoid compounds. In the present paper we describe the iso-
lation and structural determination of two methoxyﬂavonols:
3,5,7,40-tetrahydroxy-30-methoxyﬂavone (1) and 3,5,7,40-tetra-
hydroxy-8-methoxyﬂavone (2) and the vasodilator activity of
ﬂavonoid (2).
2. Experimental
2.1. Instrumentation
Melting points were measured in open capillary tubes in a
Bu¨chi 530 apparatus and are uncorrected. UV–visible spectra
were obtained on a Varian Cary 3E spectrophotometer, and IR
spectra were recorded on a Pye Unicam Perkin–Elmer spectro-
photometer. 1H and 13C NMR spectra were recorded in
DMSO-d6 on a Bruker (Wiessembourg, France) AM 300 spec-
trometer (300 and 75 MHz, for 1H and 13C NMR respectively)
and chemical shifts are given as d value with TMS as an internal
standard. EI-MS data were obtained on a Quattro II tandem
quadripole mass spectrometer (Micromass, Manchester, UK) ﬁt-
ted with an electrospray ionisation. Silica gel GF254 was used for
TLC. Spots were detected on TLC under UV light. Column chro-
matography (CC) was carried out on silica gel 60 (70–230 mesh).
2.2. Plant material
Seeds of C. villosa subsp. intermedia were collected from the
aerial part of the plant in June 2002 and again in June 2003
from Zrireg valley, plateau of Tazzeka, area of Taza, Moroc-
co. The plant was identiﬁed by Dr. Rachid El alami and Dr.
Abdeslam Ennabili (Universite´ Sidi Mohamed Ben Abdellah,
Fe`s). A voucher specimen (no. EN008) has been deposited at
the herbarium of the ‘‘Institut National des Plantes Me´dici-
nales et Aromatiques’’, Universite´ Sidi Mohamed Ben Abdel-
lah, Fe`s, Morocco.
2.3. Extraction and isolation
The powdered seeds ofC. villosa subsp. intermedia (200 g) were
extracted with MeOH in a soxhlet apparatus. After solvent
evaporation under reduced pressure, the MeOH extract
(3.50 g) was partioned between a sequence of solvents (Yang
et al., 1989). The residue from the EtOAc (1.00 g) was sub-
jected to silica gel CC using CH2Cl2 as solvent, followed by
the gradual introduction of MeOH to give a ﬂavonoids-richfraction (0.450 g). Repeated chromatography of this fraction
on silica gel column yielded pure compounds (1) (0.034 g,
eluted with CH2Cl2–MeOH 99:1) and (2) (0.015 g, eluted with
CH2Cl2–MeOH 95:5). Recrystallization of compound (2) from
methanol yielded crystals suitable for X-ray crystal analysis.
2.3.1. 3,5,7,40-tetrahydroxy-30-methoxyﬂavone (1)
Yellowish amorphous powder (0.034 g); mp 301–303 C; UV–
visible kmax nm: MeOH 255, 268 sh, 370; NaOMe 276, 320,
425; AlCl3 267, 360, 435; AlCl3 + HCl 265 sh, 358, 423; NaO-
Ac 260 sh, 275, 318 sh; NaOAc + H3BO3 260, 271 sh, 328 sh,
377; IR mmax (KBr, cm
1): 3280–3300, 2930, 1653, 1557, 1501,
1453, 1263, 1172, 1015; 1H NMR (300 MHz, dH, DMSO-d6):
11.59 (s, HO-C5), 7.67 (1H, d, J= 8.4, H-C60), 7.74 (1H, s,
H-C20), 6.93 (1H, d, J= 8.4, H-C50), 6.46 (1H, d, J= 1.8,
H-C8), 6.18 (1H, d, J= 1.8, H-C6), 3.82 (3H, s, OCH3)
ppm; 13C NMR (75 MHz, dC, DMSO-d6): 175.8 (C-4), 164.0
(C-7), 160.6 (C-5), 156.1 (C-9), 148.7 (C-2), 147.3 (C-30),
146.5 (C-40), 135.8 (C-3), 122.0 (C-60), 121.7 (C-10), 115.5 (C-
50), 111.6 (C-20), 102.9 (C-10), 98.2 (C-6), 93.6 (C-8), 55.7
(OCH3) ppm; HRMS-FAB (m/z 317.0579; calc.: 317.0583);
EI-MS m/z: 316 [M]+.
2.3.2. 3,5,7,40-tetrahydroxy-8-methoxyﬂavone (2)
Yellowish amorphous powder (0.015 g); mp 262–264 C; UV–
visible kmax nm: MeOH 272, 326 and 376; NaOMe 284, 335,
429; AlCl3 261 sh, 272, 309 sh, 359, 436; AlCl3 + HCl 261
sh, 271, 309 sh, 359, 435; NaOAc + H3BO3 273, 307 sh, 326,
377; IR mmax (KBr, cm
1): 3305, 2933, 1652, 1558, 1506,
1457, 1263, 1176, 1013; 1H NMR (300 MHz, dH, DMSO-
d6): 12.19 (s, HO-C5), 8.08 (2H, d, J= 9.0, H-C2
0, H-C60),
6.98 (2H, d, J= 9.0, H-C30, H-C50), 6.30 (1H, s, H-C6), 3.85
(3H, s, OCH3) ppm;
13C NMR (75 MHz, dC, DMSO-d6):
177.0 (C-4), 160.2 (C-7), 160.1 (C-5), 157.4 (C40), 156.4 (C-
2), 156.3 (C-9), 136.6 (C-8), 130.3 (C-3), 128.3 (C-20, C-60),
122.7 (C-10), 116.4 (C-30, C-50), 103.9 (C-10), 99.3 (C-6), 61.8
(OCH3) ppm; EI-MS m/z: 316 [M]
+.
2.4. X-ray diffraction analysis
The crystal structure of the title compound has been deter-
mined on single crystal. Data were collected on an Enraf-Non-
ius j-CCD diffractometer equipped with an Oxford
cryosystems low temperature device using a monochromator
MoKa radiation (k= 0.71073 A˚). Shelx97 was used for the
structure determination (Sheldrick et al., 1997), and full-matrix
least squares reﬁnements were based on F2.
All the non-hydrogen atoms were anisotropically reﬁned.
H atoms were located in an electron difference map, but H
atoms attached to C atoms were thereafter as riding atoms,
with C–H distances of 0.98 (CH3), 0.82 (OH) and 0.93
(C–H aromatic). The O–H bond length for water was re-
strained to 1.02(2) . No decay of intensity was observed. Per-
tinent crystallographic data and experimental conditions are
summarized in Table 1.
Supplementary tables of crystal structure and reﬁnements,
as the anisotropic thermal parameters have been deposited
[CCDC 255530, these data can be obtained free of charge using
the link: www.ccdc.cam.ac.uk or from the CCDC, 12 Union
Road Cambridge CB2 1EZ, UK; fax:+44 1223 336033;
E-mail: deposit@ccdc.cam.ac.uk].
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Table 1 Selected geometrical (A˚, ) features of (2).
Empirical formula C16H12O7Æ2H2O
Systematic name 3,5,7,40-Tetrahydroxy-
8-methoxyﬂavone
Formula weight (g/mol) 352.29
Temperature (K) 293(2)
Wavelength [kKa (A˚)] 0.71073
Crystal system Monoclinic
Space group P21/c
Unit cell dimensions (A˚, ) a= 3.8620(10) a= 90.00
b= 15.7570(5) b= 93.771(9)
c= 25.2940(10) c= 90.00
Volume (A˚3) 1535.90(9)
Z 4
dcal (g/cm
3) 1.524
Absorption coeﬃcient (mm1) 0.127
F(000) 736
Crystal size (mm) 0.2 · 0.1 · 0.05
Reciprocal space 5 6 h 6 5, 18 6 k 6 20,
27 6 l 6 32
Reﬂections collected 3437
Independent reﬂections 1899
Reﬁned parameters 239
Final R indices [I> 2r(I)] R1 = 0.0663, xR2 = 0.1801
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Male Wistar rats (250–300 g) were used. Contractions of iso-
lated aorta were measured as previously described (El Bardai
et al., 2003). Aortic rings (2 mm wide) were suspended under
a resting tension of 20 mN, in 12.5 ml organ baths ﬁlled with
a physiological solution (composition (mM): NaCl, 122;
KCl, 5.9; NaHCO3, 15; MgCl2, 1.25; CaCl2, 1.25; glucose,
11) bubbled with a gas mixture of 95% O2, 5% CO2 and main-
tained at 37 C.
After an equilibration period, each preparation was con-
tracted either by adding noradrenaline (1 lM) into the bath
solution or by changing the physiological solution in the bath
to a KCl-rich depolarizing solution, containing (in mM): KCl,
100; NaCl, 27; NaHCO3, 15; MgCl2, 1.25; CaCl2, 1.25; glu-
cose, 11. The fractions were added in the solution when the
contraction had reached a plateau. In some experiments endo-
thelium was removed by gentle rubbing.
The absence of acetylcholine (1 lM) induced relaxation in
arteries contracted with noradrenaline (1 lM) was taken as
an indicator that vessels were denuded successfully. Inhibition
of the contractions was calculated as a percentage of the con-
tractile force measured before the addition of the fraction and
was corrected for time-matched controls. pD2 values (log
IC50, concentration producing 50% inhibition of the contrac-
tion) were calculated by non-linear regression of averaged data
(GraphPad, Prism). Compound (2) was dissolved in DMSO
immediately before use.
3. Results and discussion
The seeds of C. villosa subsp. intermedia were extracted with
methanol. After the partition of the methanolic residue be-
tween water and a series of organic solvents, the ethyl acetate
fraction was investigated and yielded two ﬂavonols (1) and (2)
in a pure forme (Scheme 1). Compounds (1) and (2) displayedUV absorption and 1H-, 13C NMR data typical of ﬂavonoids
(Mabry et al., 1970). IR bands in the range of 1660–1000 cm1
are typical of a ﬂavone skeleton. The assignment of protons
and carbons in (1) and (2) are based on those given in the lit-
erature (Markham et al., 1978). Both compounds showed a
carbon signal at d 175.8 (1) and 177.0 (2).
This indicated that there are ﬂavones with a hydroxyl group
at C-5. The UV spectral data of both ﬂavones with diagnostic
shifts reagents indicated ﬂavonols with free 3, 5, 7 and 40 hy-
droxyl groups (Mabry et al., 1970). Absence of a singlet rela-
tive to C-3 proton in the 1H NMR spectra indicated that
compounds (1) and (2) are ﬂavonols. The spectral properties
of ﬂavonols (1) and (2) were veriﬁed by comparison of their
spectral data with those previously described in the literature
(Mabry et al., 1970; Markham et al., 1978; Harborne et al.,
1975).
Flavonoid (1) was obtained as a yellow powder. Its molec-
ular formula was determined to be C16H12O7 on the basis of
positive ion EI-MS (m/z 316 [M+]) and HRMS-FAB (m/z
317.0579; calc.: 317.0583). The MS-fragmentation ion at m/
z= 151 as well as the absence of m/z= 137 [if o-di-OH ring
B] were in accordance with a B ring with one hydroxyl and
one methoxyl group (Harborne et al., 1975).
The UV spectrum exhibited absorption maxima at 255 nm
(band II) and 370 nm (band I) that are characteristic absorp-
tion bands of a ﬂavone skeleton (Mabry et al., 1970). The
UV spectral data showed the presence of a free 7-OH group.
Its IR spectrum showed absorption bands due to hydroxyl
(3280–3300 cm1), aromatic keto (1653 cm1) and phenyl
and double bonds (2930, 1501, 1453 cm1) groups.
The 1H NMR spectrum of (1) displayed signals for two
meta-coupled protons at d 6.18 (1H, d, J= 1.8 Hz, H-6) and
d 6.46 (1H, d, J= 1.8 Hz, H-8). The multiplicities and the
weak coupling constants of H-6 and H-8 were in agreement
with the existence of the hydroxyl group at C-7 (d 164.0).
The chemical shifts at d 7.74, 7.67 and 6.93 were assigned to
protons in the B ring and indicated that one methoxyl group
was at 40- or 30-position.
The HMBC spectrum of compound (1) suggested that this
methoxyl group was attached to the 30-position. The UV shifts
and 1H, 13C NMR spectra of ﬂavonoid (1) were in agreement
with a quercetin skeletal pattern (Mabry et al., 1970; Harborne
et al., 1975). The only difference was that compound (1)
showed the presence of a methoxyl group at d 3.82 in the 1H
Table 2 Selected geometrical (A˚, ) features of (2).
Bond lengths (A˚)
C9 O1 1.367(3) C2 C10 1.467(3)
C2 O1 1.379(3) C2 C3 1.357(4)
O12 C4 1.266(3) C3 C4 1.436(4)
O13 C5 1.359(4) C4 C10 1.426(4)
Bond angles ()
C9 O1 C2 121.1(2) C10 C4 C3 117.3(2)
O1 C2 C3 119.8(2) C9 C10 C4 119.2(2)
C2 C3 C4 121.3(2) C9 C10 C5 118.1(3)
O12 C4 C10 122.9(2) C4 C10 C5 122.7(3)
176 A.E. Antri et al.NMR spectrum. Consequently, the structure of ﬂavonoid (1)
was established as known ﬂavonol 3,5,7,40-tetrahydroxy-30-
methoxyﬂavone (named isorhamnetin) (Simonsen et al.,
2003; Nishida, 1994).
Flavonoid (2) was isolated as a yellow powder. Its molecu-
lar formula was established as C16H12O7 by positive ion
EI-MS (m/z 316 [M+]). In the UV spectrum of (2), the maxi-
mum bands were observed at 272, 326 and 376 nm. No shift
in band I of compound (2) with the addition of AlCl3 and
AlCl3/HCl. These UV data indicated an absence of an ortho-
dihydroxyl pattern in B ring (Markham, 1982).
The IR spectrum, which was very similar to that of
ﬂavonoid (1), showed absorption bands due to hydroxyl
(3305 cm1), aromatic keto (1652 cm1) and aromatic (1457
and 1419 cm1) groups. The 1H NMR spectrum of compound
(2) displayed the characteristic signals of the kaempferol nu-
cleus: one singlet aromatic proton at d 6.30 (1H, s, H-6), ortho
coupled A2B2-type aromatic protons at d 6.98 and 8.08 (2H
each, both d, J = 9.0 Hz, H-30, H-50 and H-20, H-60 respec-
tively) and a chelate hydroxyl proton at d 12.19 (1H, broad
s, OH-5) Mabry et al., 1970; Harborne et al., 1975.
This functionality was conﬁrmed by a batochromic shift in
the UV–visible spectrum of (2) after addition of AlCl3. A
methoxyl was indicated with a signal at d 3.85 which is typical
for an 8-methoxyl group in many (but not all) ﬂavonols (Star
et al., 1975). This was conﬁrmed by the 13C NMR which
showed absence of signals around d 90–96 (C-8) replaced by
signal at d 136.6. The 13C NMR spectrum corresponds well
to the shifts of kaempferol (Harborne, 1988).
MS, IR and 1H, 13C NMR data suggested a ﬂavonol substi-
tuted with four hydroxyl groups and one methoxyl group.
Therefore, the structure of ﬂavonol (2) was established to be
3,5,7,40-tetrahydroxy-8-methoxyﬂavone previously identiﬁed
in several samples of Spanish honey (Ferreres et al., 1991),
and obtained by acid hydrolysis of Sedum sexangulare’s leaves
(Combier et al., 1968) and of 8-methoxykaempferol-3-sop-
horoside isolated from almond pollen (Prunus amygdalus)
Ferreres et al., 1989. However, as far as we know, this is the
ﬁrst reported occurrence of a 3,5,7,40-tetrahydroxy-8-meth-
oxyﬂavone aglycone in plant.Figure 1 Perspective view, (Diamond Brandenburg, 1999), of
the molecule of ﬂavonoid (2). Thermal ellipsoids drawn at 50%
probability levels.3.1. X-ray structure determination
The structure of ﬂavonoid (2) was unambiguously determined
by single crystal X-ray diffraction analysis (Fig. 1). Suitable
crystals for X-ray studies were obtained from methanol by
slow evaporation. Selected geometrical parameters, bond
lengths and angles are listed in Table 2 according to the num-
bering scheme displayed in Fig. 1.
Flavonoid (2) crystallizes in the monoclinic P21/c space
group with one organic molecule and two molecules of water
comprising the asymetric unit (Fig. 1). The structure has re-
vealed the basic ﬂavone core similar to the other ﬂavonoids re-
ported in the litterature, i.e. a benzene ring (A) condensed with
a six-membered ring (C), which in the 2-position caries a phe-
nyl ring (B) as a substituent, see Scheme 1 (Mabry et al., 1970;
Markham et al., 1978; Harborne et al., 1975).
The squeletal atoms of the two fused six-membered rings
deﬁne good planes which are substantially coplanar with the
associated phenyl ring. The corresponding dihedral angle
being 169.6. This conﬁguration is in favour of a possible con-
jugation between the electronic systems of the two units, whichFigure 2 Dimer [(C16H12O7)Æ2H2O]2 in the crystal ofﬂavonoid (2).
Figure 3 A projection, along [1 0 0], of the crystal structure of ﬂavonoid (2).
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C10-C2 [1.467(3) A˚].
The methoxy group at C8 being not planar with the associ-
ated ring because a coplanar disposition would interfere
sterically with O14 and H20. Torsion angle O15 C8 C7 C6
being of 176.3. The smaller C5–O13–H13 angle of 109.5 indi-
cates that intramolecular attractive forces are possible (O13–
H13.....O12). The usual intramolecular O14–H14. . .O15
(methoxy), O11–H11. . ...O12 (ketone) and O13–H13. . ...O12
(ketone) interactions are respectively 2.314(6) A˚, 2.249(6) A˚
and 1.874(5) A˚.
Moreover, there is an important intermolecular interactions
[2.003(8) A˚], via the dipole O17–H17, contributing to the for-
mation of pair of molecules [(C16H12O7)Æ2H2O]2 in the crystal
of the title compound (Fig. 2). The deﬁned ‘‘dimers’’ interactFigure 4 Effect of ﬂavonol (2) on the contraction of isolated rat
aorta.via the remaining hydroxyl groups to propagate the crystal
in the three dimensional as can be seen on Fig. 3.
The dimers form tunnels, parallel to [1 0 0], where locate
water molecules. These laters reinforce the cohesion between
the molecules by adding supplementary H bonds. As might
be expected with such almost planar molecules, as it is the case
here, the lattice array is dominated by a parallel disposition of
molecular planes, with appreciable overlap characteristic of
the presence of charge-transfer interactions and numerous
non-hydrogen atom contacts <4 A˚.
The vasodilator activity of ﬂavonol (2) was tested in rat
aorta. Flavonol (2) inhibited the contractions evoked by high
KCl or by noradrenaline in a concentration-dependent manner
as shown in Fig. 4. In endothelium-denuded aorta, pD2 (-lo-
gIC50) values for the inhibition of the contraction were
4.37 ± 0.04 and 4.58 ± 0.03 for contractions evoked by
100 mM KCl and noradrenaline, respectively.
The inhibitory potency of ﬂavonol (2) against KCl-evoked
contraction was not signiﬁcantly affected by endothelium re-
moval (pD2 4.52 ± 0.05). The present results indicate that ﬂa-
vonol (2) exhibits similar vasodilator potency as that of
quercetin (Ibarra et al., 2003).
Contraction was evoked by 100 mM KCl solution, or by
noradrenaline (Nad, 1 lM) in rings of endothelium-intact
(E(+)), or endothelium-denuded (E()) aorta. Data are means
from 4 to 6 determinations.
4. Conclusion
This is the ﬁrst report of the isolation of these ﬂavonols from
C. villosa subsp. intermedia. It is worthy to notice that it is also
the ﬁrst reported occurrence of a 3,5,7,40-tetrahydroxy-8-meth-
oxyﬂavone (2) aglycone in plant and its ﬁrst X-ray crystal
structure determination.
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